Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLXW) EBT (2020 - 2025)

Scilex Holding has reported EBT over the past 6 years, most recently at -$257.8 million for Q3 2025.

  • Quarterly results put EBT at -$257.8 million for Q3 2025, down 5775.55% from a year ago — trailing twelve months through Sep 2025 was -$338.7 million (down 286.02% YoY), and the annual figure for FY2024 was -$72.8 million, up 36.31%.
  • EBT for Q3 2025 was -$257.8 million at Scilex Holding, down from -$44.0 million in the prior quarter.
  • Over the last five years, EBT for SCLXW hit a ceiling of $21.5 million in Q3 2022 and a floor of -$257.8 million in Q3 2025.
  • Median EBT over the past 5 years was -$18.6 million (2021), compared with a mean of -$29.6 million.
  • Biggest five-year swings in EBT: crashed 295894.66% in 2021 and later surged 7732.69% in 2022.
  • Scilex Holding's EBT stood at -$18.6 million in 2021, then rose by 3.94% to -$17.8 million in 2022, then dropped by 19.88% to -$21.4 million in 2023, then soared by 69.8% to -$6.5 million in 2024, then plummeted by 3890.39% to -$257.8 million in 2025.
  • The last three reported values for EBT were -$257.8 million (Q3 2025), -$44.0 million (Q2 2025), and -$30.4 million (Q1 2025) per Business Quant data.